mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-09 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-08 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
9e-06 |